The most favourable genotype for SSRI metabolism includes CYP2D6, CYP2C19 and SLC6A – but the findings show a low prevalence.

Genotyping of patients treated with selective serotonin reuptake inhibitors | Tidsskrift for Den norske legeforening (tidsskriftet.no)

Share this post